Bringing Early-Phase Product Development Strategies in Practise

Gerard Dunne is Managing Director of BELTAS™ CRO founded with his business colleague in 2003 and operating in New Zealand, Australia and Europe.  He has a BSc (Hons) from Canterbury University, is a member of the US-based international Project Management Institute and a qualified Project Management Professional.

BELTAS™ clients range from start-up companies to Top-10 pharmaceutical and medical device corporations, in New Zealand, Australia and the United States.  The company has managed Phase I-IV clinical trials to ICH & FDA standards in New Zealand, Australia, Canada, the Netherlands, Belgium, France and the United Kingdom.

BELTAS™ organizes and presents the US-based Association of Clinical Research Professionals’ ICH Good Clinical Practice training program in New Zealand.

Gerard is on the editorial board of Good Clinical Practice Journal (GCPj) based in London.